Video-based discussion tool to help families of kids with cancer talk about goals of care
Official title: A Multisite RWCT Comparing the Effectiveness of a Goals of Care Video and Navigator Intervention, the VIDEO-PEDS Experience, Versus Usual Care in Pediatric Cancer
Run by Massachusetts General Hospital · NCT06786104 · Data updated 2026-11-12
A video-based intervention (VIDEO-PEDS) is tested to see if it helps clinicians and parents of children with cancer better document and decide on goals of care and end-of-life plans.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 567 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 4 sites (Birmingham, Alabama and 3 other locations) |
| Status | Recruiting |
| Started | May 5, 2026 |
| Main results expected | January 15, 2030 |
| Study ends | April 15, 2030 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT06786104 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Parents who are decision-makers for a child with cancer (age 0-12) receiving active cancer-directed treatment and who can view English or Spanish video materials.
✕Probably not a fit
Parents or children who cannot view the videos (e.g., visual impairment beyond 20/200 even with assistive options) or who do not consent to participate may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a video-guided decision aid designed for parents of children with cancer to improve communication about goals of care. It uses a two-phase approach with a pilot feasibility phase followed by a randomized waitlist-controlled trial to measure effects on documentation, care choices, hospital use, and parent satisfaction. The trial aims to refine the intervention and assess its preliminary impact on both clinical processes and patient-family outcomes. Eligible participants include children up to age 12 receiving cancer-directed treatment and their parents who can view the videos in English or Spanish. The study is led by Massachusetts General Hospital with multiple collaborators and sites in Alabama, Georgia, and Massachusetts.
Why it matters
Potential benefit: If successful, the tool could help families have clearer discussions about goals of care and align treatment with their values, potentially reducing unwanted invasive interventions and increasing access to palliative care.
How similar studies have gone: Previous adult cancer studies with video decision aids showed improved communication and alignment of care with patient preferences; pediatric applicability is being tested in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient * Age 0-12 years * Diagnosed with any type or stage of cancer * Receiving cancer directed treatment Parent * Decision maker for the child. * Biological parent, step-parent, legal guardian (e.g., adoptive parent), or grandparent with medical consent authority. * Has a child meeting the child inclusion criteria listed above. * Able to communicate in English or Spanish (the languages of the video decision aids). Exclusion Criteria: Patient * Not receiving primary medical care from the cancer clinic (e.g., second-opinion consultations only) * Already referred to and fully consulted by the palliative care team * Prognosis of less than a 2-month life expectancy Parent * Visually impaired beyond 20/200 corrected and unable to view the video (note: hearing impaired is not an exclusion as the videos are closed captioned). * Psychological state not appropriate for GOC discussions, as determined by the primary oncologist per the opt-out. * Participants who do not speak English or Spanish
Where it's running
-
Children's of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting -
Children's Hospital of Atlanta
Atlanta, Georgia, United States Recruiting -
Dana Farber Cancer Institute
Boston, Massachusetts, United States Recruiting -
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States Active not recruiting
Study contacts
- Principal investigator: Angelo Volandes, MD — Dartmouth-Hitchcock Medical Center
- Study coordinator: Joanne E Wolfe, MD
- Email: jwolfe@mgh.harvard.edu
- Phone: 6177242911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.